OXB (LSE: OXB), a global quality and innovation-led cell and gene therapy CDMO, today announces it has been recognised with the ‘Most Innovative CDMO (Cell & Gene Therapy)’ award at the CDMO ...

Collaboration Leverages Made Scientific's Industry Expertise and Workforce Development Initiative to Empower the Next Generation of Cell and Gene Therapy Professionals PRINCETON, N.J. and NEWARK, N.J.

Applied StemCell, Inc. (“ASC”), a genome engineering company with deep expertise in induced pluripotent stem cell (iPSC) technology and Cellipont Bioservices, a cell therapy contract development and ...

The MarketWatch News Department was not involved in the creation of this content. BANGALORE, India, Jan. 3, 2025 /PRNewswire/ -- Cell Therapy and Gene Therapy CDMO Market is Segmented by Type (Cell ...

Sartorius has collaborated with ElevateBio, a cell therapy CDMO, among other partners, to test the Eveo platform.

SINGAPORE, March 11, 2026 /PRNewswire/ -- Locus Cell Co., Ltd. ("Locus Cell"), a Taiwan-based cell and gene therapy (CGT) Contract Development and Manufacturing Organization (CDMO), and Charles River ...

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Kincell Bio announced the completion of a $22 million round, led by a new investor, NewSpring Capital through its dedicated healthcare strategy, ...

GOTTINGEN, GERMANY / ACCESS Newswire / March 16, 2026 / Sartorius launches next-generation platform to boost efficiency in ...

Less than three months after its formation, Minaris Advanced Therapies has appointed its first CEO. Orla Cloak, who has 20 years of commercial leadership experience in the life-sciences industry, ...